Lee CL, Toomey S, Farrelly A, Hennessy B, et al. Preclinical drug testing and clinical trial planning of palbociclib (CDK4/6 inhibitor) drug combination with a PI3K or MAPK inhibitor for colorectal cancer (CRC). Ann Oncol 2019;30 Suppl 1:i7.
PMID: 32081166